Finance

Lists
Why is EPRX down 7,77%?
Dive Deeper
EPRX:TSE
Eupraxia Pharmaceuticals Inc
10,32 CA$
-7,77%
(-0,87) 1D
2 қаз., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for EPRX...
Open
11,36 CA$
High
11,41 CA$
Low
10,26 CA$
Mkt. cap
671,00 млн
Avg. vol.
82,24 мың
Volume
171,00 м.
52-wk high
13,08 CA$
52-wk low
7,35 CA$
EPS
-1,34 CA$
Beta
1,05
Shares outstanding
65,91 млн
No. of employees
49
Open
11,36 CA$
High
11,41 CA$
Low
10,26 CA$
Mkt. cap
671,00 млн
Avg. vol.
82,24 мың
Volume
171,00 м.
52-wk high
13,08 CA$
52-wk low
7,35 CA$
EPS
-1,34 CA$
Beta
1,05
Shares outstanding
65,91 млн
No. of employees
49
News stories
From web sources and news partners
About Eupraxia Pharmaceuticals Inc
CEO-
Employees49
Founded2011
HeadquartersВиктория, Британдық Колумбия, Канада
Sector-
Websiteeupraxiapharma.com
Last report
2026 ж. 11 там.
Fiscal period
Q2 2026
EPS / Est. (CAD)
-0,32 CA$ / -
Revenue / Est. (CAD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,42 млн
7,87 млн
11,17 млн
12,81 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,47 млн
8,30 млн
4,78 млн
5,30 млн
Operating expense
6,88 млн
16,16 млн
15,96 млн
18,10 млн
Total operating expenses
6,88 млн
16,16 млн
15,96 млн
18,10 млн
Operating income
-6,88 млн
-16,16 млн
-15,96 млн
-18,10 млн
Other non operating income
-
-
-
-
EBT including unusual items
-6,37 млн
-16,71 млн
-12,64 млн
-14,46 млн
EBT excluding unusual items
-6,37 млн
-16,71 млн
-12,64 млн
-14,46 млн
Income tax expense
-623,00
11,34 мың
13,90 мың
30,38 мың
Effective tax rate
0,01%
-0,07%
-0,11%
-0,21%
Other operating expenses
-
-
-
-
Net income
-6,36 млн
-16,71 млн
-12,65 млн
-14,49 млн
Net profit margin
-
-
-
-
Earnings per share
-0,19
-
-
-
Interest and investment income
180,18 м.
666,92 м.
1,07 млн
1,39 млн
Interest expense
-
-
-
-
Net interest expenses
180,18 м.
666,92 м.
1,07 млн
1,39 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,84 млн
-16,11 млн
-15,90 млн
-18,02 млн
Gain or loss from assets sale
-
1,49 мың
-
2,70 мың
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары